Skip to main content

A Cure in Sight

Raleigh, North Carolina·EIN 46-1274306·NTEE H12 · Medical Research·501(c)(3)·Filing year 2023
Total revenue
$409k
Total assets
$197k
Total expenses
$491k
Reported officers
4

How A Cure in Sight’s pay compares

Its latest Form 990 lists no roles we can compare, so there is no comparison for it yet.

Chief Executive Officer pay at Medical Research organizations of similar size in the South Atlantic states

25th
$69k
Median
$124k
75th
$142k

From the Form 990 filings of 15 Medical Research organizations of similar size in the South Atlantic states.

See Chief Executive Officer pay in full

A Cure in Sight's mission is to provide funding for patient services for ocular melanoma eye cancer patients education awareness and research.

Reported officers (all unpaid)

No paid executives reported in 2023. A Cure in Sight reported 4 unpaid officers and board members on its 990.

President
Secretary
Treasurer
Vice President

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

What the Chief Executive Officer earns at organizations like this one

A Cure in Sight reported no executive compensation in its latest filing. For context, the Chief Executive Officer at Medical Research organizations of similar size in the South Atlantic states earns a median of $124,111.

25th percentile
$69k
Median
$124,111
75th percentile
$142k
90th percentile
$152k

These are pay figures for organizations like this one, not this organization's reported pay. Based on 15 organizations. There were too few similar organizations to compare with, so this group goes beyond North Carolina.

See full Medical Research compensation data →

Common questions about A Cure in Sight

What are A Cure in Sight's revenue and expenses?

In 2023, A Cure in Sight reported $409k in total revenue and $491k in total expenses on its IRS Form 990.